Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Non-cash Items (2019 - 2022)

Edesa Biotech's Non-cash Items history spans 6 years, with the latest figure at $1.2 million for Q2 2022.

  • For Q2 2022, Non-cash Items changed N/A year-over-year to $1.2 million; the TTM value through Jun 2022 reached $1.2 million, changed N/A, while the annual FY2021 figure was $821706.0, 75.46% up from the prior year.
  • Non-cash Items for Q2 2022 was $1.2 million at Edesa Biotech, up from $1.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.2 million in Q2 2022 and bottomed at $232190.0 in Q2 2019.
  • The 4-year median for Non-cash Items is $495728.0 (2020), against an average of $615979.5.
  • The largest annual shift saw Non-cash Items surged 94.53% in 2020 before it surged 63.49% in 2022.
  • A 4-year view of Non-cash Items shows it stood at $268923.0 in 2019, then soared by 94.53% to $523136.0 in 2020, then skyrocketed by 57.07% to $821706.0 in 2021, then skyrocketed by 50.04% to $1.2 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Non-cash Items are $1.2 million (Q2 2022), $1.1 million (Q1 2022), and $821706.0 (Q3 2021).